Quick Answer
OnKure Therapeutics, Inc. reported Total Assets of $62.12 million for fiscal year 2025.
OnKure Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $62.12M | -45.9% |
| 2024 | $114.91M | +221.6% |
| 2023 | $35.73M | -67.0% |
| 2022 | $108.18M | -29.8% |
| 2021 | $154.02M | +178.9% |
| 2020 | $55.22M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $72.83M | -6.2% | -15.4% |
| June 30, 2025 | $86.07M | +9.3% | -13.8% |
| March 31, 2025 | $99.88M | +18.0% | -13.1% |
| December 31, 2024 | $114.91M | +7.0% | +48.0% |
| September 30, 2024 | $77.64M | -40.5% | -1.4% |
| June 30, 2024 | $78.72M | -46.8% | -7.0% |
| March 31, 2024 | $84.64M | -14.4% | -21.2% |
| December 31, 2023 | $107.44M | -0.7% | -17.6% |
- OnKure Therapeutics, Inc. showed a decrease of -45.9% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, OnKure Therapeutics, Inc.’s total assets has grown by 12.5% (from $55.22 million to $62.12 million).
- The most recent figure is from OnKure Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: